Literature DB >> 21420592

Risk factors for steroid response among cataract patients.

David F Chang1, Jeffrey J Tan, Yorghos Tripodis.   

Abstract

PURPOSE: To evaluate the age and ocular axial length (AL) of topical steroid responders after uneventful cataract surgery.
SETTING: Private practice, Los Altos, California, USA.
DESIGN: Case-control study.
METHODS: This retrospective chart review comprised consecutive patients from a single-surgeon practice who had cataract surgery during a 2-year period. All patients routinely received topical prednisolone acetate 1.0% postoperatively. In addition to AL and patient age, the intraocular pressure (IOP) was recorded preoperatively, 1 day postoperatively, and at least 1 additional time in the first postoperative month while the patient was taking a topical corticosteroid agent. A steroid response was defined as an IOP increase greater than 25% while on topical prednisolone (minimum 28 mm Hg) followed by a decrease of more than 25% after topical prednisolone was discontinued. The age and AL were compared between steroid responders with nonresponders.
RESULTS: Of the 1642 patients, 39 were diagnosed as steroid responders. Younger age and a longer AL were associated with a higher risk for steroid response, particularly in patients younger than 65 years with an AL of at least 29.0 mm. These patients had a 39-fold increased risk for an IOP higher than 28 mm Hg and a 35-fold increased risk for an IOP higher than 35 mm Hg than patients older than 65 years with a normal AL.
CONCLUSION: Younger patients with high myopia had a higher risk for a postoperative steroid response after uneventful cataract surgery and may require more frequent IOP monitoring or alternative topical antiinflammatory medications. FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.
Copyright © 2011 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21420592     DOI: 10.1016/j.jcrs.2010.10.051

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  17 in total

Review 1.  Do we need day-1 postoperative follow-up after cataract surgery?

Authors:  Andrzej Grzybowski; Piotr Kanclerz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-12-19       Impact factor: 3.117

Review 2.  [Pharmacological treatment strategies and surgical options for uveitis].

Authors:  Justus G Garweg
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

3.  Injectable drug depot engineered to release multiple ophthalmic therapeutic agents with precise time profiles for postoperative treatment following ocular surgery.

Authors:  Maziar Mohammadi; Kisha Patel; Seyedeh P Alaie; Ron B Shmueli; Cagri G Besirli; Ronald G Larson; Jordan J Green
Journal:  Acta Biomater       Date:  2018-04-21       Impact factor: 8.947

Review 4.  Risk factors for open-angle glaucoma and recommendations for glaucoma screening.

Authors:  Alexander K Schuster; Felix M Wagner; Norbert Pfeiffer; Esther M Hoffmann
Journal:  Ophthalmologe       Date:  2021-04-21       Impact factor: 1.059

Review 5.  Clinical Applications of Dexamethasone for Aged Eyes.

Authors:  Beatriz Abadia; Pilar Calvo; Antonio Ferreras; Fran Bartol; Guayente Verdes; Luis Pablo
Journal:  Drugs Aging       Date:  2016-09       Impact factor: 3.923

6.  Intraocular pressure effects of common topical steroids for post-cataract inflammation: are they all the same?

Authors:  Uwe Pleyer; Paul G Ursell; Paolo Rama
Journal:  Ophthalmol Ther       Date:  2013-09-17

Review 7.  Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure.

Authors:  John D Sheppard; Timothy L Comstock; Megan E Cavet
Journal:  Adv Ther       Date:  2016-03-17       Impact factor: 3.845

8.  Incidence and risk factors for postoperative intraocular pressure response to topical prednisolone eye drops in patients undergoing phacoemulsification.

Authors:  Sharmila Rajendrababu; Srilekha Pallamparthy; Anusha Arunachalam; Mohammed Sithiq Uduman; Senthilkumari Srinivasan; S R Krishnadas; Vijayalakshmi A Senthilkumar
Journal:  Int Ophthalmol       Date:  2021-07-26       Impact factor: 2.031

9.  A Randomized, Controlled, Prospective Study of the Effectiveness and Safety of an Intracanalicular Dexamethasone Ophthalmic Insert (0.4 Mg) for the Treatment of Post-Operative Inflammation in Patients Undergoing Refractive Lens Exchange (RLE).

Authors:  Jacob Larsen; Travis Whitt; Briana Parker; Russell Swan
Journal:  Clin Ophthalmol       Date:  2021-05-27

10.  De novo ocular hypertension after Descemet stripping endothelial keratoplasty: comparative 3-year incidence, risk factors, and outcomes.

Authors:  Errol W Chan; Tina T Wong; Hla M Htoon; Ching L Ho; Donald T Tan; Jodhbir S Mehta
Journal:  Clin Ophthalmol       Date:  2013-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.